Affiliation:
1. Institute of Genetics and Biophysics ‘Adriano Buzzati-Traverso’, CNR, 80131 Naples, Italy
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of <8% [...]
Funder
Fondazione Umberto Veronesi
Fondazione Italiana per la ricerca sulle Malattie del Pancreas
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference47 articles.
1. Pancreatic Ductal Adenocarcinoma: Treatment Hurdles, Tumor Microenvironment and Immunotherapy;Sarantis;World J. Gastrointest. Oncol.,2020
2. Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A., and Bray, F. (2020). Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology, 159.
3. Translational Advances in Pancreatic Ductal Adenocarcinoma Therapy;Hosein;Nat. Cancer,2022
4. Pancreatic Cancer Stroma: An Update on Therapeutic Targeting Strategies;Hosein;Nat. Rev. Gastroenterol. Hepatol.,2020
5. Targeting the Tumour Stroma to Improve Cancer Therapy;Valkenburg;Nat. Rev. Clin. Oncol.,2018